Ruokonen E, Takala J, Kari A, Saxén H, Mertsola J, Hansen E J
Department of Intensive Care, Kuopio University Hospital, Finland.
Crit Care Med. 1993 Sep;21(9):1296-303. doi: 10.1097/00003246-199309000-00011.
To measure the blood flow distribution and regional oxygen transport in hyperdynamic septic shock during hypotension and after correction by vasopressor doses of dopamine or norepinephrine.
Prospective, randomized, controlled trial.
Tertiary care center.
Ten patients with hyperdynamic septic shock (ages ranging from 45.1 +/- 16.6 yrs) and a control group of 11 postoperative cardiac surgery patients (ages ranging from 54.8 +/- 7.9 yrs).
Systemic and regional hemodynamics and oxygen transport were measured in ten patients with hyperdynamic septic shock during hypotension and after vasopressor therapy (norepinephrine or dopamine). Oxygen consumption (VO2) was measured by indirect calorimetry and splanchnic and leg blood flow with indocyanine green infusion.
Splanchnic blood flow and VO2 (p < .05) were increased in septic shock during hypotension and during vasopressor therapy. Both dopamine and norepinephrine increased systemic blood flow and VO2 independently of the arterial lactate level. Despite the relatively small changes in systemic oxygen transport, major regional changes occurred in oxygen delivery and VO2, and these changes were unpredictable from systemic changes.
Regional changes in oxygen transport in septic shock cannot be predicted from the changes in the whole body. The increased oxygen demand in the splanchnic region is the main risk factor for splanchnic tissue hypoxia in septic shock.
测量在低血压状态下以及使用多巴胺或去甲肾上腺素血管升压剂量纠正后,高动力型感染性休克患者的血流分布和局部氧输送情况。
前瞻性、随机、对照试验。
三级医疗中心。
10例高动力型感染性休克患者(年龄范围为45.1±16.6岁)以及11例心脏手术后患者组成的对照组(年龄范围为54.8±7.9岁)。
对10例高动力型感染性休克患者在低血压状态下以及血管升压治疗(去甲肾上腺素或多巴胺)后测量全身和局部血流动力学及氧输送情况。通过间接测热法测量氧耗量(VO2),并通过注入吲哚菁绿测量内脏和腿部血流。
在低血压状态下及血管升压治疗期间,感染性休克患者的内脏血流和VO2(p < 0.05)增加。多巴胺和去甲肾上腺素均独立于动脉乳酸水平增加全身血流和VO2。尽管全身氧输送变化相对较小,但氧输送和VO2发生了主要的局部变化,且这些变化无法从全身变化中预测。
感染性休克中氧输送的局部变化无法从全身变化中预测。内脏区域氧需求增加是感染性休克中内脏组织缺氧的主要危险因素。